title: [Cocaine, ANCA, and Wegener's granulomatosis].
authors.forename: M L
authors.initials: ML
authors.lastname: Morassi
authors.forename: M
authors.initials: M
authors.lastname: Trimarchi
authors.forename: P
authors.initials: P
authors.lastname: Nicolai
authors.forename: G
authors.initials: G
authors.lastname: Gregorini
authors.forename: R
authors.initials: R
authors.lastname: Maroldi
authors.forename: U
authors.initials: U
authors.lastname: Specks
authors.forename: F
authors.initials: F
authors.lastname: Facchetti
mesh_terms: D000280:Administration, Inhalation; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000032:analysis* / Q000276:immunology; D001327:Autoimmune Diseases / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D003042:Cocaine / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D014890:Granulomatosis with Polyangiitis / Q000175:diagnosis* / Q000276:immunology / Q000473:pathology; D006801:Humans; D009300:Nasal Septum / Q000187:drug effects* / Q000473:pathology; D011237:Predictive Value of Tests; D014456:Ulcer / Q000139:chemically induced / Q000175:diagnosis / Q000276:immunology / Q000473:pathology
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D003042:Cocaine